Isabelle Sinapi

1.4k total citations
14 papers, 123 citations indexed

About

Isabelle Sinapi is a scholar working on Oncology, Surgery and Hepatology. According to data from OpenAlex, Isabelle Sinapi has authored 14 papers receiving a total of 123 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 4 papers in Surgery and 3 papers in Hepatology. Recurrent topics in Isabelle Sinapi's work include Colorectal Cancer Treatments and Studies (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Cancer Genomics and Diagnostics (3 papers). Isabelle Sinapi is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Cancer Genomics and Diagnostics (3 papers). Isabelle Sinapi collaborates with scholars based in Belgium, France and United States. Isabelle Sinapi's co-authors include Marc Van den Eynde, Nicolas D. Huyghe, Javier Carrasco, Aline van Maanen, Alain Hendlisz, Jérôme Galon, Marc Peeters, Sandra Schmitz, Jean-Pascal Machiels and Benoı̂t Navez and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Cancers.

In The Last Decade

Isabelle Sinapi

11 papers receiving 122 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isabelle Sinapi Belgium 7 82 49 32 32 25 14 123
Q. Molenaar Netherlands 6 38 0.5× 67 1.4× 24 0.8× 39 1.2× 6 0.2× 14 115
Guillaume Conroy France 7 31 0.4× 32 0.7× 13 0.4× 41 1.3× 17 0.7× 9 120
Roberta Grande Italy 8 83 1.0× 53 1.1× 22 0.7× 25 0.8× 22 0.9× 16 135
Hatim Karachiwala Canada 6 58 0.7× 19 0.4× 37 1.2× 79 2.5× 21 0.8× 21 147
C.-H. Köhne Germany 6 131 1.6× 35 0.7× 46 1.4× 34 1.1× 28 1.1× 12 143
Nuria Truán Spain 5 101 1.2× 89 1.8× 33 1.0× 6 0.2× 13 0.5× 6 146
Cameron J Fairfield United Kingdom 5 33 0.4× 108 2.2× 26 0.8× 59 1.8× 9 0.4× 8 152
Wen-sheng Jin China 4 23 0.3× 53 1.1× 34 1.1× 28 0.9× 5 0.2× 6 125
P. Bercelli France 4 71 0.9× 49 1.0× 59 1.8× 15 0.5× 19 0.8× 7 117
Toshio Otsuji Japan 5 60 0.7× 39 0.8× 33 1.0× 56 1.8× 8 0.3× 9 93

Countries citing papers authored by Isabelle Sinapi

Since Specialization
Citations

This map shows the geographic impact of Isabelle Sinapi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Sinapi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Sinapi more than expected).

Fields of papers citing papers by Isabelle Sinapi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Sinapi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Sinapi. The network helps show where Isabelle Sinapi may publish in the future.

Co-authorship network of co-authors of Isabelle Sinapi

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Sinapi. A scholar is included among the top collaborators of Isabelle Sinapi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Sinapi. Isabelle Sinapi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
3.
Baldin, Paméla, Javier Carrasco, Anne Jouret‐Mourin, et al.. (2022). Randomized Phase 2 Study Comparing Pathological Responses of Resected Colorectal Cancer Metastases after Bevacizumab with mFOLFOX6 or FOLFIRI (BEV-ONCO Trial). Cancers. 14(5). 1183–1183. 2 indexed citations
4.
Huyghe, Nicolas D., Isabelle Sinapi, Fazulur Rehaman Vempalli, et al.. (2022). Interim analysis of the phase II AVETUXIRI trial: Avelumab combined with cetuximab and irinotecan for treatment of refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC).. Journal of Clinical Oncology. 40(16_suppl). 3595–3595. 8 indexed citations
5.
6.
7.
Duhoux, François P., et al.. (2016). Tumor lysis syndrome following trastuzumab and pertuzumab for metastatic breast cancer: a case report. Journal of Medical Case Reports. 10(1). 178–178. 8 indexed citations
8.
Robays, Jo, Leen Verleye, Roos Leroy, et al.. (2015). Pooled analysis of the surgical treatment for colorectal cancer liver metastases. Critical Reviews in Oncology/Hematology. 94(1). 122–135. 25 indexed citations
9.
Peeters, Marc, Roos Leroy, Jo Robays, et al.. (2014). Colon Cancer. 1 indexed citations
10.
Patrikidou, Anna, Isabelle Sinapi, Hélène Regnault, et al.. (2014). Gemcitabine and oxaliplatin chemotherapy for advanced hepatocellular carcinoma after failure of anti-angiogenic therapies. Investigational New Drugs. 32(5). 1028–1035. 20 indexed citations
11.
Vos, Martine De, et al.. (2013). Multiple myeloma presenting as hepatic nodular lesion.. PubMed. 67(5). 378–80.
12.
Sinapi, Isabelle, Benoı̂t Navez, Marc Hamoir, et al.. (2012). Seeding of the percutaneous endoscopic gastrostomy site from head and neck carcinoma: Case report and review of the literature. Head & Neck. 35(7). E209–12. 16 indexed citations
13.
Sinapi, Isabelle, Frank Hammer, & Pierre Hainaut. (2010). AORTIC MURAL THROMBI ASSOCIATED WITH ULCERATIVE COLITIS. Acta Clinica Belgica. 65(1). 54–55. 3 indexed citations
14.
Sinapi, Isabelle, et al.. (2010). Fibrose rétropéritonéale et myélome multiple : association fortuite ?. La Revue de Médecine Interne. 31(5). e4–e6.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Q. Molenaar Breakdown of academic impact, for papers by Guillaume Conroy Breakdown of academic impact, for papers by Roberta Grande Breakdown of academic impact, for papers by Hatim Karachiwala Breakdown of academic impact, for papers by C.-H. Köhne Breakdown of academic impact, for papers by Nuria Truán Breakdown of academic impact, for papers by Cameron J Fairfield Breakdown of academic impact, for papers by Wen-sheng Jin Breakdown of academic impact, for papers by P. Bercelli Breakdown of academic impact, for papers by Toshio Otsuji
Rankless by CCL
2026